Swedbank AB Acquires New Position in Astera Labs, Inc. $ALAB

Swedbank AB acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 44,200 shares of the company’s stock, valued at approximately $8,654,000.

A number of other large investors also recently bought and sold shares of ALAB. Great Valley Advisor Group Inc. increased its holdings in shares of Astera Labs by 2.2% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after acquiring an additional 90 shares during the last quarter. Straight Path Wealth Management lifted its stake in Astera Labs by 1.5% during the second quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock worth $619,000 after purchasing an additional 100 shares during the last quarter. First Horizon Advisors Inc. boosted its holdings in Astera Labs by 12.4% in the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after purchasing an additional 108 shares during the period. Advisors Asset Management Inc. increased its stake in Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after purchasing an additional 194 shares during the last quarter. Finally, Berbice Capital Management LLC raised its holdings in shares of Astera Labs by 14.3% during the second quarter. Berbice Capital Management LLC now owns 1,600 shares of the company’s stock worth $145,000 after purchasing an additional 200 shares during the period. Institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the subject of several research reports. Cowen reaffirmed a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. TD Cowen decreased their target price on Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a research note on Wednesday, November 5th. Needham & Company LLC upped their target price on Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Citigroup reiterated an “outperform” rating on shares of Astera Labs in a research report on Tuesday, December 9th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a report on Tuesday, September 2nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus price target of $188.17.

Insider Activity at Astera Labs

In other news, CEO Jitendra Mohan sold 90,459 shares of the stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the transaction, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the sale, the director owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 586,936 shares of company stock worth $89,331,140 in the last ninety days. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs Trading Down 1.6%

Shares of NASDAQ:ALAB opened at $167.26 on Friday. The firm’s 50 day moving average is $159.77 and its two-hundred day moving average is $158.19. The firm has a market capitalization of $28.25 billion, a P/E ratio of 150.68, a PEG ratio of 3.12 and a beta of 1.51. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same period in the previous year, the firm posted $0.23 earnings per share. The business’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.